These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 807441)

  • 1. Thyrotrophin and prolactin responsiveness to thyrotrophin releasing hormone in Cushing's disease.
    Kuku SF; Child DF; Nader S; Fraser TR
    Clin Endocrinol (Oxf); 1975 Jul; 4(4):437-42. PubMed ID: 807441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies of the basal secretion and the response to TRH (thyrotropin-relapsing factor) of TSH (thyrotropin) and prolactin in Cushing's syndrome and Nelson's syndrome (author's transl)].
    Luton JP; Molinie P; Strauch G; Guilhaume B; Bricaire H
    Sem Hop; 1981 May 8-15; 57(17-18):841-9. PubMed ID: 6262921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum prolactin and thyrotrophin responses to thyrotrophin-releasing hormone at different times of the day in normal women.
    Pérez-López FR; Gómez Agudo G; Abós MD
    Acta Endocrinol (Copenh); 1981 May; 97(1):7-11. PubMed ID: 6784427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSH secretion in Cushing's syndrome: relation to glucocorticoid excess, diabetes, goitre, and the 'sick euthyroid syndrome'.
    Benker G; Raida M; Olbricht T; Wagner R; Reinhardt W; Reinwein D
    Clin Endocrinol (Oxf); 1990 Dec; 33(6):777-86. PubMed ID: 2128925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anterior pituitary function in Cushing's syndrome: study of 36 patients.
    Cuerda C; Estrada J; Marazuela M; Vicente A; Astigarraga B; Bernabeu I; Diez S; Salto L
    Endocrinol Jpn; 1991 Oct; 38(5):559-63. PubMed ID: 1843276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma.
    Comtois R; Beauregard H; Hardy J; Robert F; Somma M
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):601-7. PubMed ID: 8392915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of apomorphine on basal and TRH stimulated release of thyrotrophin and prolactin in man.
    Nilsson KO; Wide L; Hökfelt B
    Acta Endocrinol (Copenh); 1975 Oct; 80(2):220-9. PubMed ID: 809954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocorticotropin and cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushing's disease.
    Pieters GF; Smals AG; Goverde HJ; Pesman GJ; Meyer E; Kloppenborg PW
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1188-97. PubMed ID: 6290524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotrophin and prolactin responses to thyrotrophin-releasing hormone in patients with Parkinson's disease.
    Martinez-Campos A; Giovannini P; Novelli A; Cocchi D; Caraceni T; Müller EE
    Acta Endocrinol (Copenh); 1982 Mar; 99(3):344-51. PubMed ID: 6803485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of suckling and of suckling followed by TRH or LH-RH on plasma prolactin, TSH, GH and FSH.
    Jeppsson S; Nilsson KO; Rannevik G; Wide L
    Acta Endocrinol (Copenh); 1976 Jun; 82(2):246-53. PubMed ID: 818858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum thyrotrophin, prolactin and growth hormone, response to TRH during oestrogen treatment.
    Rutlin E; Haug E; Torjesen PA
    Acta Endocrinol (Copenh); 1977 Jan; 84(1):23-35. PubMed ID: 401551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT; Luria M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of thyroxine, 3,5,3'-triiodothyronine, thyrotropin, and prolactin in dogs before and after thyrotropin-releasing hormone administration.
    Kaufman J; Olson PN; Reimers TJ; Allen TA; Soderberg SF; Nett TM; Wheeler SL; Wingfield WE
    Am J Vet Res; 1985 Feb; 46(2):486-92. PubMed ID: 3922262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of nocturnal elevation of plasma prolactin concentrations in Cushing's disease.
    Krieger DT; Howanitz PJ; Frantz AG
    J Clin Endocrinol Metab; 1976 Feb; 42(2):260-72. PubMed ID: 816805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotrophin and prolactin responses to thyrotrophin-releasing hormone in patients with streak gonad syndrome.
    Bösze P; Kóvacs Z; Egyed J; László J; Szilágyi G
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):179-84. PubMed ID: 6402863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pituitary ACTH, GH, LH, FSH, TSH and prolactin reserves in patients with Cushing's syndrome.
    Hashimoto K
    Endocrinol Jpn; 1975 Feb; 22(1):67-77. PubMed ID: 805044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid-stimulating hormone, prolactin, and growth hormone response to thyrotropin-releasing hormone in treated children with congenital hypothyroidism.
    Sack J; Shafrir Y; Urbach D; Amado O
    Pediatr Res; 1985 Oct; 19(10):1037-9. PubMed ID: 3932951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
    Andreassen B; Huth J; Tyson JE
    Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.